Sarepta Therapeutics’ $313.5 Million Convertible Senior Notes Exchange

Ropes & Gray advised Sarepta Therapeutics on the deal.Sarepta Therapeutics, Inc. announced separate, privately negotiated exchange agreements with certain holders of its 1.50% Convertible Senior Notes…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now